Institutional investors hold a majority ownership of PDLI through the 95.61% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2014, these large investors purchased a net $706.8 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST ASSET INVESTMENT MANAGEMEN... Bought 71.4 Thousand shares of PDL BioPharma Inc
QUONIAM ASSET MANAGEMENT GMBH Bought 49.3 Thousand shares of PDL BioPharma Inc